Encompass HealthMEX:EHC 88 EBITDA Margin % is 25.70% as of Mar. 2026, which is 20% above its 10-year median of 21.33. GuruFocus rates MEX:EHC with a GF Score™ of 88/100 and a GF Value™ of MXN1,344.64. The stock has 1 warning sign investors should review. Among 666 Healthcare Providers & Services companies, Encompass Health ranks better than 83.33% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Encompass Health's EBITDA for the
three
months ended in Mar. 2026 was MXN7,354 Mil. Encompass Health's Revenue for the
three
months ended in Mar. 2026 was MXN28,611 Mil. Therefore, Encompass Health's EBITDA margin for the quarter that ended in Mar. 2026 was 25.70%.
Encompass Health (MEX:EHC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Encompass Health EBITDA Margin % Related Terms
Encompass Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Encompass Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:EHC vs ENSG, UHS, PACS: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Encompass Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Encompass Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health (MEX:EHC) has a EBITDA Margin % of 25.70% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Encompass Health and its competitors. This is 20% above median its historical median of 21.33. Over the past decade, Encompass Health's EBITDA Margin % has ranged from 19.64 to 24.11. According to the industry distribution chart, Encompass Health ranks #111 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 16.7%.
Is Encompass Health's EBITDA Margin % too high?
Encompass Health's current EBITDA Margin % of 25.70% is 20% above median its 10-year median of 21.33. Over the past 10 years, this metric has ranged from a low of 19.64 to a high of 24.11. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Encompass Health's value of 25.70% is 151.7% above this industry median. Based on the distribution chart, Encompass Health ranks #111 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Encompass Health has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's EBITDA Margin % compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #111 out of 666 companies for EBITDA Margin %. This places Encompass Health in the top 17% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Encompass Health's value of 25.70% is 151.7% above this benchmark. Historically, Encompass Health's own EBITDA Margin % has ranged from 19.64 to 24.11 over the past decade. While the company's 10-year median is 21.33 vs. the industry median of 10.21, Encompass Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current EBITDA Margin % of 25.70% is 151.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current EBITDA Margin % is 25.70%, which is 20% above median its own 10-year median of 21.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Encompass Health (MEX:EHC) has a current EBITDA Margin % of 25.70%. The stock's GF Value™ is MXN1,344.64, compared to a current price of MXN1,280.08 — trading 4.8% below its estimated fair value. The current EBITDA Margin % is 25.70%, which is 20% above median its 10-year median of 21.33 and 151.7% above the Healthcare Providers & Services industry median of 10.21. Encompass Health's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current EBITDA Margin % is 25.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be undervalued.
The current stock price of MXN1,280.08 is trading 4.8% below its estimated GF Value™ of MXN1,344.64.
Key valuation signals for MEX:EHC:
EBITDA Margin %: 25.70% (20% above median its 10-year median of 21.33)
GF Value™: MXN1,344.64 vs. price of MXN1,280.08 (4.8% below fair value)
Industry Position: 151.7% above the Healthcare Providers & Services median (#111 of 666)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
88GF Score
Get the complete analysis for MEX:EHC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
